Abazistobart - CAS 3002062-67-8

Abazistobart is an immunostimulant and antitumor agent targeting programmed cell death protein 1 (PDCD1) . This chimeric humanized monoclonal antibody specifically binds to PDCD1, blocking associated signaling pathways, thereby activating the immune system to exert antitumor effects. Abazistobart holds promise for cancer research applications.

PD-1/PD-L1

Apoptosis, Immunology/Inflammation, Cell Cycle/Checkpoint

3002062-67-8

-20°C

Ice Packs

Inhibitory Antibodies